Rapid Responses to:

LETTERS: John G F Cleland Time for a proper study of aspirin after a vascular event? BMJ 2008; 337: a2583 [Full text]

Rapid Responses: Submit a response to this article

Rapid Responses published:

Dilemma of Aspirin

Ajay G. Pise, Anup Naha, Dinesh Kumar, Shilpa Dua, Venkat Raghvan, N. Udupa   (20 November 2008)

Dilemma of Aspirin 20 November 2008
Ajay G. Pise, Lecturer Department of Pharmacy Management, Manipal College of Pharmaceutical Sciences, Manipal 576104, India, Anup Naha, Dinesh Kumar, Shilpa Dua, Venkat Raghvan, N. Udupa Send response to journal: Re: Dilemma of Aspirin	In one or other way Aspirin has frequently retaining its place in healthcare journals and magazines. The debate on “effectiveness and safety” of aspirin is continuous. Scientific journal states its relation with Atherosclerotic Cardiovascular Disease. Research Journals says that long term trials of aspirin shown a reduction in mortality and morbidity. Conclusion part of most of the research articles add in dilemma of aspirin. Though the study published in Lancet advocates the use of aspirin, it needs a lot of research to make a conclusion and clear the air. Competing interests: None declared